Prevalence and characterization of interstitial lung disease in a lung cancer screening program
R. Calzado Lopez (MADRID, Spain), C. Gotera Rivera (MADRID, Spain), T. Pérez Warnisher (MADRID, Spain), R. Melchor Iñiguez (MADRID, Spain), J. Pinillos Robles (MADRID, Spain), E. Cabezas Pastor (MADRID, Spain), A. El Hachem Debek (MADRID, Spain), M. Rodríguez Guzmán (MADRID, Spain), P. Lazo Meneses (MADRID, Spain), J. Alfayate Sánchez (MADRID, Spain), N. González Mangado (MADRID, Spain), G. Peces Barba (MADRID, Spain), L. Seijo Maceiras (MADRID, Spain)
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Session: Innovations in idiopathic pulmonary fibrosis
Session type: Thematic Poster
Number: 1324
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Calzado Lopez (MADRID, Spain), C. Gotera Rivera (MADRID, Spain), T. Pérez Warnisher (MADRID, Spain), R. Melchor Iñiguez (MADRID, Spain), J. Pinillos Robles (MADRID, Spain), E. Cabezas Pastor (MADRID, Spain), A. El Hachem Debek (MADRID, Spain), M. Rodríguez Guzmán (MADRID, Spain), P. Lazo Meneses (MADRID, Spain), J. Alfayate Sánchez (MADRID, Spain), N. González Mangado (MADRID, Spain), G. Peces Barba (MADRID, Spain), L. Seijo Maceiras (MADRID, Spain). Prevalence and characterization of interstitial lung disease in a lung cancer screening program. 1324
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: